We are live on
!
Find out more
First Manhattan Portfolio holdings
AUM
$36.1B
1-Year Est. Return
11.5%
This Fund
S&P 500
This Quarter
Est. Return
+9.64%
1 Year Est. Return
+11.5%
3 Year Est. Return
+74.65%
5 Year Est. Return
+103.66%
10 Year Est. Return
+354.63%
AUM
$27.3B
AUM Growth
+$1.22B
(+4.7%)
Cap. Flow
-$932M
Cap. Flow
% of AUM
-3.41%
Top 10 Holdings %
Top 10 Hldgs %
60.57%
Holding
1,588
New
70
Increased
176
Reduced
495
Closed
161
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$128M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$67.4M |
| 3 |
XIFR
XPLR Infrastructure LP
XIFR
|
+$63.8M |
| 4 |
UnitedHealth
UNH
|
+$57.4M |
| 5 |
Danaher
DHR
|
+$24.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$760M |
| 2 |
Amazon
AMZN
|
+$68.5M |
| 3 |
AbbVie
ABBV
|
+$54.2M |
| 4 |
PPLI
People Inc
PPLI
|
+$36.8M |
| 5 |
PNC Financial Services
PNC
|
+$29.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 44.09% |
| 2 | Technology | 18.28% |
| 3 | Healthcare | 10.34% |
| 4 | Consumer Discretionary | 7.89% |
| 5 | Communication Services | 5.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
BlackRock Core Bond Trust
BHK
$642M
| $339K | ﹤0.01% |
31,900
| – | – |
|
552
Corning
GLW
$126B
| $339K | ﹤0.01% |
9,661
-3,000
| -24% | -$98.6K |
|
553
Nucor
NUE
$56.4B
| $338K | ﹤0.01% |
2,060
| – | – |
|
554
Eversource Energy
ES
$28.2B
| $337K | ﹤0.01% |
4,752
-3,185
| -40% | -$237K |
|
555
Amerant Bancorp
AMTB
$1.12B
| $335K | ﹤0.01% |
19,500
| – | – |
|
|
AL
556
DELISTED
Air Lease Corp
AL
| $335K | ﹤0.01% |
8,000
| – | – |
|
557
iShares Morningstar Value ETF
ILCV
$1.3B
| $333K | ﹤0.01% |
5,000
| – | – |
|
558
Trane Technologies
TT
$106B
| $330K | ﹤0.01% |
1,725
| – | – |
|
559
Palo Alto Networks
PANW
$264B
| $327K | ﹤0.01% |
2,562
-39,910
| -94% | -$4.15M |
|
560
Target
TGT
$62.1B
| $327K | ﹤0.01% |
2,479
-1,418
| -36% | -$210K |
|
561
Whirlpool
WHR
$2.42B
| $323K | ﹤0.01% |
2,168
+1,568
| +261% | +$215K |
|
562
Paychex
PAYX
$40.4B
| $322K | ﹤0.01% |
2,881
-96
| -3% | -$10.5K |
|
563
McKesson
MCK
$98.5B
| $319K | ﹤0.01% |
746
| – | – |
|
564
Willis Towers Watson
WTW
$27.9B
| $314K | ﹤0.01% |
1,333
-1,159
| -47% | -$267K |
|
565
Northeast Bank
NBN
$1.11B
| $313K | ﹤0.01% |
7,500
| – | – |
|
566
Cooper Companies
COO
$13.7B
| $312K | ﹤0.01% |
3,260
| – | – |
|
567
Peloton Interactive
PTON
$2.63B
| $312K | ﹤0.01% |
40,550
+20,000
| +97% | +$170K |
|
568
RB Global
RBA
$20.8B
| $304K | ﹤0.01% |
5,066
-221
| -4% | -$12.5K |
|
|
BLFY
569
DELISTED
Blue Foundry Bancorp
BLFY
| $303K | ﹤0.01% |
30,000
| – | – |
|
570
Vanguard S&P 500 Growth ETF
VOOG
$25.4B
| $302K | ﹤0.01% |
7,122
-66
| -0.9% | -$2.62K |
|
571
Estee Lauder
EL
$29B
| $301K | ﹤0.01% |
1,533
+43
| +3% | +$9.12K |
|
572
Huntsman Corp
HUN
$2.24B
| $299K | ﹤0.01% |
11,050
+10,050
| +1,005% | +$261K |
|
573
iShares Russell 1000 ETF
IWB
$47.7B
| $298K | ﹤0.01% |
1,224
| – | – |
|
|
MRO
574
DELISTED
Marathon Oil Corporation
MRO
| $298K | ﹤0.01% |
12,927
| – | – |
|
575
iShares Core S&P US Value ETF
IUSV
$27.2B
| $297K | ﹤0.01% |
3,797
-9,175
| -71% | -$685K |
|
Similar funds
SAM
First Manhattan's Q2 2023 Portfolio in Review
As of Q2 2023, First Manhattan held 1,588 positions worth $27.3B, up 4.7% from $26.1B the previous quarter. Its ten largest holdings account for 61% of the portfolio.
First Manhattan withdrew a net $932M in Q2 2023, closing 161 positions and reducing 495 holdings. Its most notable exit was Enanta Pharmaceuticals, an estimated $10.7M position sold in full.
By sector, the portfolio is most concentrated in Financials at 44% of assets, down from 45% a quarter earlier, followed by Technology and Healthcare.
Against the trend, First Manhattan opened a new position in Mersana Therapeutics worth $1.87M.
- First Manhattan's largest Q2 2023 buy was Mersana Therapeutics: 22,784 shares worth $1.87M.
- First Manhattan added most to Thermo Fisher Scientific in Q2 2023, an estimated $128M increase.
- First Manhattan's biggest Q2 2023 reduction was Berkshire Hathaway Class A, cutting an estimated $760M.
- First Manhattan fully exited Enanta Pharmaceuticals in Q2 2023, selling an estimated $10.7M.
- First Manhattan's ten largest holdings make up 61% of its $27.3B portfolio in Q2 2023.
- First Manhattan opened 70 new positions and closed 161 in Q2 2023.
- First Manhattan's portfolio value rose 4.7% quarter-over-quarter to $27.3B.
Based on First Manhattan's 13F filing for Q2 2023, filed 14 Aug 2023.